SCHEMBL7230640

SCHEMBL7230640

N#Cc1ccccc1-c1ccc(C(=O)N[C@@H]2C[C@H]3CC[C@@H]2N3)o1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.45
▸ RAB9A P51151 4/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ HTT P42858 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ KDM1A O60341 1/20 0.39
▸ SLC6A2 P23975 2/20 0.39
▸ SLC6A4 P31645 2/20 0.39
▸ SLC6A3 Q01959 1/20 0.39
▸ UTS2R Q9UKP6 1/20 0.37
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7234830 0.85 RAB9A (0.42) NPC1RAB9AHTTSMN1; SMN2MEN1
SCHEMBL7225840 0.84 RAB9A (0.41) NPC1RAB9AALDH1A1HTTSMN1; SMN2
SCHEMBL7072612 0.84 RAB9A (0.49) NPC1RAB9AALDH1A1HTTSMN1; SMN2
SCHEMBL7226764 0.84 RAB9A (0.53) NPC1RAB9AALDH1A1HTTSMN1; SMN2
SCHEMBL7231145 0.84 SLC9A1 (0.44) NPC1RAB9AHTTSMN1; SMN2LMNA
SCHEMBL7233102 0.84 ALDH1A1 (0.49) NPC1RAB9AALDH1A1HTTSMN1; SMN2
SCHEMBL7226523 0.83 SMN1; SMN2 (0.42) NPC1RAB9AALDH1A1HTTSMN1; SMN2
Hydrochloric Acid SCHEMBL7070829 0.83 RAB9A (0.48) NPC1RAB9AALDH1A1HTTSMN1; SMN2
SCHEMBL7231428 0.83 FAAH (0.46) KDM1ASLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7232158 0.82 ALDH1A1 (0.50) NPC1RAB9AALDH1A1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 — — US claimed
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 — — US disclosed
Send feedback